Tinea unguium
ICD-10 B36.1 is a billable code used to indicate a diagnosis of tinea unguium.
Tinea unguium, also known as onychomycosis, is a fungal infection that affects the nails, particularly the toenails. It is characterized by nail discoloration, thickening, and potential separation from the nail bed. The condition is primarily caused by dermatophytes, although non-dermatophyte molds and yeasts can also be responsible. Tinea unguium is more prevalent in individuals with compromised immune systems, diabetes, or peripheral vascular disease. Symptoms may include nail brittleness, crumbling, and a foul odor. Diagnosis is typically made through clinical examination and confirmed by laboratory tests such as nail clippings or scrapings analyzed via culture or microscopy. Treatment options include topical antifungal agents like ciclopirox and systemic antifungals such as terbinafine or itraconazole, which are often necessary for more severe cases. The management of tinea unguium can be challenging, particularly in immunocompromised patients, as they may experience more severe infections and complications. Regular follow-up and monitoring are essential to ensure treatment efficacy and to prevent recurrence.
Detailed clinical notes on nail appearance, symptoms, and treatment response.
Patients presenting with nail discoloration, thickening, or pain.
Consideration of patient history, including previous treatments and comorbidities.
Foot examination findings, including nail health and any associated foot conditions.
Patients with diabetes or peripheral vascular disease presenting with nail issues.
Importance of assessing vascular status and potential complications.
Used when significant nail dystrophy is present.
Document the extent of debridement and the condition of the nails.
Podiatrists may perform this procedure more frequently in diabetic patients.
Common treatments include topical antifungals like ciclopirox and systemic antifungals such as terbinafine and itraconazole, depending on the severity of the infection.
